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Abstract: Paraoxonase 1 (PON1) contributes to the antioxidant mechanisms that prevent lipoprotein oxidation and act as a negative
acute-phase protein. This study aimed to evaluate changes in serum PON1 activity, the leukocyte PON1 gene expression, as well as lipid
profile tests (LDL, HDL, triglyceride, and cholesterol) in 16 healthy Darehshori newborn foals up to 60 days of life. Blood samples were
collected at 1, 7, 15, 30, and 60 days used for detecting biochemical parameters, PON1 activity, and, and its gene expression, using realtime RT-PCR. Low levels of PON1 activity were observed at birth, which increased significantly with increasing age at days 7, 15, 30, and
60. In addition, HDL levels were significantly increased at 15, 30, and 60 days in male foals, and in contrast, LDL and cholesterol levels
were significantly reduced on days 15, 30, and 60 compared to the first day of life in newborn foals. For the first time, PON1 mRNA was
detected in foal leukocytes and its gene expression showed a significant decrease compared to the birthday. The positive correlations
between PON1 expression/HDL, LDL, and cholesterol in the first week of life and between PON1 enzyme activity/ HDL, LDL, and
cholesterol in different samples and sexes may indicate an adaptive increase in antioxidant defenses in response to oxidative stress. The
authors suggest that PON1 expression in leukocytes may be related to the enzyme’s ability to reduce intracellular oxidant levels.
Key words: Horse, neonatal foals, paraoxonase, lipid profile, gene expression

1. Introduction
The health of newborn foals may be affected by the
metabolic and nutritional status of the mare during
pregnancy, parturition, and postpartum periods [1]. It
is well known that oxidant/antioxidant balance has a
comprehensive influence on the health of farm animals
[2]. The antioxidant defense system has protective effects
against proinflammatory mediators and oxidative stress
[3]. In this regard, paraoxonase-1 (PON1) is found in a
variety of mammalian species that act as antiinflammatory
and antioxidant enzymes and mainly hydrolyze
organophosphates [4]. Paraoxonase has a wide range
of substrates and different catalytic activities, including
lactonase and arylesterase, and acts as a negative acutephase protein (APP) [5–7]. PON1 is primarily expressed
in the liver [5,6]. PON1 prevents high-density lipoprotein
cholesterol (HDL-C) oxidation by hydrolyzing specific
lipid peroxides [7]. In turn, HDL is necessary for PON1
secretion, distribution, stability, and activity. Therefore, any
changes in the structure and composition of HDL could
explain the reduced activity and hepatic gene expression

of PON1 [7,8]. Serum PON1 concentration has been
regulated by several factors, such as genes, age, sex, lifestyle,
and pharmaceutical interventions [9]. Additionally, PON1
has been demonstrated to protect against prenatal and
postnatal organophosphate (OP) toxicity in animal studies.
[10]. Generally, low serum PON1 is related to different
diseases such as atherosclerosis, diabetes, cancer, chronic
renal failure, and hepatic disorders. Serum PON1 activity
decreases in inflammatory conditions and oxidative
stress, too. Therefore, the activity of this enzyme could be
considered a potential biomarker for many pathological
conditions and also as a part of the innate immune system
[4, 11]. PON1 activities were also investigated in diseased
animals [11,12]. It was indicated that measurement of
PON1 activity might be useful to evaluate the progression
of inflammatory conditions in horses [7,13]. Recently,
paraoxon‐based methods have been validated to measure
serum PON1 activity of equine serum samples, and
reference intervals have been established for this species.
It was also suggested that the assessment of PON1 activity
is useful to correctly classify healthy and sick horses [14].
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Even though the fact that PON1 plays a significant role
in clinical diagnostic work in horses, there has been no
research on the changes in serum PON1 activity and gene
expression in healthy newborn foals. Van Lenten et al. [15]
pointed out the presence of the PON1 gene in the liver
of laboratory animals. Ruggerone et al. [14] suggest that
serum PON1 is inactivated during acute phase response
and its hepatic gene expression is inhibited as well. The foal
liver biopsy, on the other hand, necessitates anesthesia and
laparoscopic or ultrasonography guides, which are costly,
time-consuming, and potentially life-threatening [16].
Because liver biopsy is a very invasive method, determining
paraoxonase gene expression in the circulating leukocytes
can be considered a safer strategy. Moreover, it is indicated
that PON2, another member of the paraoxonase family,
is involved in reducing the intracellular oxidative stress
of macrophages [17]. But research on PON1 expression
in leukocytes is still not available. Therefore, the purpose
of the present study was to investigate the PON1 gene
expression in leukocytes, lipid profile, and serum PON1
activity in newborn foals for the first time.
2. Materials and methods
2.1. Animals and experimental design
The experimental procedures were approved by the
guidelines of Shahrekord University (Shahrekord, Iran) for
the care and use of animals )Date: 8.9.2020, No: 190.2218).
Thirty-two pregnant mares were monitored closely until
parturition, and 16 healthy newborn Darehshori foals
(8 females and 8 males) were selected. All foals were
born under staff supervision and remained with mares
throughout the experiment. All of the foals in this study
were fed and kept in similar conditions. The newborn foals
received adequate colostrum. The study was designed to
last 60 days.
2.2. Sample collection
Blood collection was carried out by jugular venipuncture
after birth as well as 7, 15, 30, and 60 days of age, using
tubes containing sodium heparin for plasma and a
nonanticoagulant tube for serum. The samples were
centrifuged at 4000 rpm for 10 min. Serum was collected
to determine the lipid profile and PON1 activity and stored
at –20 °C until use. The plasma was discarded and a buffy
coat was used to evaluate PON1 gene expression.
2.3. Measurement of serum PON1 activity
Serum PON1 activity was assessed using a commercial
kit (ZellBio, Ulm, Germany, catalog number: ZB-PON48A) according to the manufacturer’s instructions. The
hydrolysis of paraoxon to p-nitrophenol produces a yellow
color. The wavelength was monitored at 0 and 2 min at
412 nm by a colorimeter. Enzyme activity was calculated
according to the following formula:
Enzyme activity (U/mL) = OD / 0.0008.

2.4. Lipid profile assay
Triglyceride (TG) and total cholesterol (TC) concentrations
were measured using an enzymatic colorimetric assay
(Pars Azmoon kits, Tehran, Iran, catalog numbers: GPOPAP, CHOD-PAP) by an automatic serum auto-analyzer
(BT3000, Italy). The level of HDL-C was assayed by using
enzymatic kits (Bionic Diagnostic Kit, Tehran, Iran,
catalog number: 20.04 LTS) according to the colorimetric
method based on standard manual kit procedures with the
utilization of an auto analyzer. Low-density lipoprotein
cholesterol (LDL-C) was calculated according to Friedwald
et al. [18].
2.5. RNA isolation and cDNA synthesis
Total RNA was extracted from the collected blood samples
using the RNX-Plus solution according to the company
manual (Sinaclone, Iran, catalog number: RN7713C). The
quantity and quality of the purified RNAs were verified by
a nanodrop spectrophotometer and electrophoresis using
1% agarose gel, respectively. Approximately 50 ng of RNA
was used for the complementary DNA (cDNA) synthesis
using a cDNA synthesis kit (Vivantis, Malaysia, catalog
number: cDsk01-050) according to its manufacturer’s
protocol. Synthesized cDNA was kept at –20 °C until it
was used.
2.6. Primer design and qRT-PCR experiment
The specific primers were designed with the GeneRunner
software, tested with the NCBI Primer Blast, and
synthesized by CinnaGen (CinnaGen Co, Tehran, Iran).
The full properties of the designed primer are accessible in
Table 1. The GAPDH gene was used as an internal control
gene for relative gene expression analysis [19]. Real-time
RT-PCR was performed. Each reaction contained 0.5 μL of
cDNA, 0.5 μL of 0.4 μM solutions of each of the forward and
reverse primers and 5 μL of 2 × SYBR green master mix in
a total volume of 10 μL. Then, all strip tubes were entered
into the StepOne Real-Time PCR (Applied Biosystems,
Carlsbad, CA, USA). For PCR amplification, the following
steps were undertaken: initial denaturation at 95 °C for 15
min, 40 cycles at 95 °C for 10 s, 55 °C for 30 s, then 72 °C
for 30 s. Finally, the fold changes were calculated using the
2-ΔΔCT method by Livak and Schmittgen [20].
2.7. Statistical analysis
The data is normalized via the Shapiro–Wilk test and
SigmaPlot 14 version (Systat Software Inc.) program was
used to analyze the data (mean ± SEM) using repeated
measure one-way analysis of variance (RM ANOVA) and
Pearson correlation at the p < 0.05 level. Dunnett’s method,
Tukey’s and Holm–Sidak tests were also used for multiple
comparisons of data.
3. Results
In both sexes, PON1 activity increased significantly from
birth onwards, and conversely, leukocyte PON1 gene
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expression and serum levels of LDL and cholesterol were
reduced on days 15, 30, and 60 compared to the first day
of life (p < 0.05) (Table 2). The comparison of lipid profiles
(cholesterol, LDL, HDL, and triglycerides), PON1 activity,
and PON1 gene expression rate in female and male foals is
described in (Table 3). At the age of two months, positive
correlations occurred between TG/PON1 activity (r =
+0.689, p = 0.019) and TG/PON1 expression (r = +0.74,
p = 0.009). The relationship between TG/PON1 activity
had already occurred on the day of birth (r = +0.671, p =
0.0239). From the first week onwards, a positive correlation
occurred between cholesterol/HDL, cholesterol/LDL,
LDL/HDL, and triglyceride/HDL (Table 4).
Serum PON1 activity was low in female foals at birth
and increased significantly at 7, 15, 30, and 60 days of age
compared to the birthday (p = 0.005, p = 0.001, p = 0.002,
and p = 0.002, respectively). Similarly, serum PON1 activity
of male foals increased with age and exhibited higher levels
at 7, 15, 30, and 60 days of age (p < 0.001) compared to
the first day of life. The age-associated increase in serum
PON1 activity was higher in male foals at 30 and 60 days
than in females. However, this increase was not statistically
significant (Table 3 and Figure 1).

The decreasing trend of gene expression in female
foals continued up to 60 days of life, and only a significant
increase was observed at 30 days compared to 15 days
(p = 0.036). There were also significant reductions in
cholesterol and LDL concentrations that occurred in 30
and 60 days compared to the first day of female life (Table
3 and Figure 2). Positive correlations were found between
PON1 expression/cholesterol, LDL and HDL at 7 days (r =
+0.706, p = 0.0151; r = +0.688, p = 0.0193 & r = +0.662, p
= 0.0265) and negative ones with triglyceride at 60 days of
age (r = –0.643, p = 0.033) (Table 4).
On the first day of female life, a positive and negative
correlation were recorded between cholesterol/LDL
(r = +0.996, p = 0.000127) and TG/HDL (r = –0.9, p =
0.037), respectively. Afterward, paraoxonase activity/HDL
experienced a negative correlation (r = –0.901, p = 0.0364)
at 7 days of age, but other correlations (HDL/LDL, HDL/
TG, and TG/cholesterol) were positive at this time and also
at 15 days of age (p < 0.05). In the first month of life, only a
positive correlation occurred between LDL/cholesterol (r
= +0.97, p = 0.000631) (Table 4).
In male foals, HDL increased at 15, 30, and 60 days,
and in contrast, serum LDL was reduced at 60 days

Table 1. Sequences of oligonucleotide primers used for qRT-PCR analysis.
Gene
GAPDH
PON1

Primers

Sequence

Forward

5-GGTCGGAGTAAACGGATTTGGC-3

Reverse

5- CTGAAACATGTAGACCATGTAG -3

Forward

5’- GTTATATTTGGGTTTAGCATGG-3’

Reverse

5’- CATAGACATACTTGCCATCAGG-3’

Product size
(bp)

Accession number

130

XR_546436.1

125

XM_001493403.6

bp: Base pair.
Table 2. Serum lipid profiles, PON1 activity and, its leukocyte gene expression (mean ± SEM) in Darehshori newborn foals up to 60
days of age.
Parameters
Days of
sampling

PON1
mRNA (fold change)

PON1 activity
(U/mL)

LDL
(mg/dL)

HDL
(mg/dL)

TG
(mg/dL)

Cholesterol
(mg/dL)

1

0.807 ± 0.102

23.23 ± 3.02

213.57 ± 36.93

56.72 ± 3.29

85.54 ± 15.62

297.45 ± 38.76

7

0.25 ± 0.043a, c

53.16 ± 4.23a

152.27 ± 34.36

70.63 ± 5.26

89 ± 14.72

240.36 ± 40.14

15

0.26 ± 0.029

60.33 ± 4.25

125.3 ± 18.04

67.72 ± 4.96

68.63 ± 14.82

202.63 ± 23.4a

30

0.255 ± 0.02a, c

61.55 ± 4.93a

108.52 ± 12.54a

62.63 ± 2.57

52.81 ± 7.58b

181.72 ± 14.87a

60

0.15 ± 0.024

64.34 ± 4.56

87.85 ± 6.79

66.27 ± 4.22

43.18 ± 6.62

165 ± 9.24a

a, c

a

Significant to the birthday (p < 0.05).
Significant to the 7th day (p < 0.05).
c
Significant to the 60th day (p < 0.05).
a

b
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Table 3. Serum lipid profile, PON1 activity and, its leukocyte gene expression in female and male foals (mean ± SEM) from birth up to
the 60th day of life.
Parameters
Days of
sampling
1
7
15
30
60

Sex of foals PON1 mRNA
(fold change)

PON1 activity
(U/mL)

LDL
(mg/dL)

HDL
(mg/dL)

TG
(mg/dL)

Cholesterol
(mg/dL)

Female

0.91 ± 0.086

29.087 ± 5.12

261.1 ± 73.37 a, A

64.8 ± 3.52

122.4 ± 25.8

362.6 ± 69.3

Male

0.72 ± 0.172

13.36 ± 4.39

173.93 ± 26.87

50 ± 3.41

54.83 ± 5.81

243.16 ± 31.7

Female

0.307 ± 0.09

53.29 ± 6.13

174.68 ± 74.37

79 ± 9.44

86.4 ± 18.84

270.2 ± 86.8

Male

0.205 ± 0.022

53.06 ± 6.37

133.6 ± 22.09

63.66 ± 4.56

91.16 ± 23.5

215.5 ± 24.6

Female

0.24 ± 0.029

60.37 ± 7.57a

114.96 ± 37.92

68 ± 9.3

59.2 ± 13.91

194.8 ± 49.75

a

a

a

a

Male

a, c

0.277 ± 0.05

58.63 ± 5.25

133.91 ± 14.2

67.5 ± 5.7

76.5 ± 25.49

209.16 ± 18.4

Female

0.282 ± 0.026b

56.6 ± 6.56 a

75.2 ± 8.67a

57.6 ± 2.06

48 ± 7.68

142.4 ± 10.6a, A

Male

0.233 ± 0.029a, d

82.35 ± 22.5a

136.3 ± 13.69

66.83 ± 3.7a

56.83 ± 12.8

214.5 ± 16.2

Female

0.21 ± 0.028a, A

57.38 ± 4.7 a

73.58 ± 9.4a

61.6 ± 3.61

25.4 ± 3.02aA

146 ± 7.19 a, A

Male

0.098 ± 0.024

68.14 ± 7.82

58 ± 7.76

180.83 ± 12.97

a

a

a

99.75 ± 6.93

a

a

70.16 ± 7.1

a

Significant to the birthday (p < 0.05).
Significant to the 15th day (p < 0.05).
c
Significant to the 30th day (p < 0.05).
d
Significant to the 60th day (p < 0.05).
A
Significant to another sex on the same day (p < 0.05).
a

b

compared to the birthday (p < 0.05). A positive correlation
was recorded between LDL/cholesterol (r = +0.952, p
= 0.0034) on day 1 and also between LDL/paraoxonase
activity (r = +0.9, p = 0.0146), LDL/cholesterol (r = +0.932,
p = 0.0067) and HDL/TG (r = +0.87, p = 0.0243) on day
7. On the 15th day of their lives, positive correlations
were found between paraoxonase activity/cholesterol
(r = +0.983, p = 0.00042) and HDL/TG (r = +0.861, p
= 0.0278). It was found that serum PON1 activity was
positively correlated with cholesterol (r = +0.878, p =
0.0214) and LDL (r = +0.902, p = 0.0139) and also LDL/
cholesterol (r = +0.943, p = 0.00476) on the 30th day. On
the 60th day of life, cholesterol was positively correlated
with HDL (r = +0.914, p = 0.0108) and LDL (r = +0.828, p
= 0.042). A positive correlation was found between PON1
expression/HDL and triglyceride at 7 days (r = +0.849, p
= 0.0326 and r = +0.834, p = 0.0389, respectively) (Tables
3 and 4).
The comparison between sexes revealed that female
serum LDL concentration was significantly higher than that
of male foals (p = 0.001) up to the 30th day of life, and after
that, LDL and cholesterol levels were significantly reduced
compared to males (p < 0.001). Similarly, in the second
month, serum cholesterol and triglyceride concentrations
of female foals were lower than those of males (p = 0.008
and p = 0.015, respectively). The reduction in the relative
expression of PON1 from birth to 60 days was significantly
greater in males than female foals, so that on day 60 it

reached 0.0988 ± 0.0242 compared to 0.211 ± 0.028 for
females (p = 0.023).
4. Discussion
PON1 has been shown to be involved in oxidative stress,
lipid metabolism, and immunity [4]. Variations in PON1
activity have been observed in many pathologic conditions
[13,14]. Despite extensive research to assay PON1 activity
in different species, it has not been evaluated in newborn
foals yet. Therefore, in the present study, the authors
attempted to investigate changes in leukocyte PON1 gene
expression, PON1 activity, and lipid profile in healthy
newborn foals up to 60 days of age in the current study.
According to the obtained results, PON1 activity was at
a low level on the first day of life and increased significantly
up to the 60th day. Interestingly, antioxidant defense and
PON1 activity of newborn babies are at a lower level too,
which increases with age and reaches an adult level at 6
months to 2 years [21,22]. These findings are consistent
with those mentioned by Giordano et al. [23].
Low PON1 activity has been reported in other
newborn species, and Ruggerone et al. [14] believe that
the lower PON1 activity in neonates could be associated
with hepatic immaturity, differences in lipid metabolism,
and more susceptibility to oxidative stress. According to
Matyas and Zaharie [22], the cause of increasing PON1
activity with age could be associated with the enhancement
of antioxidant abilities. In the present study, similar to that

641

642
Triglyceride
(mg/dL)
Cholesterol (mg/dL)

r = +0.671, P = 0.0239
& r = +0.689, P = 0.019
BS, 1 & 60 Days

BS: Both sexes, F: Female foals, M: Male foals.

Cholesterol
(mg/dL)

TG
(mg/dL)

HDL (mg/dL)

LDL
(mg/dL)

+ (>7 days)
r = –0.9, P = 0.037
F, Day 1
+ (>7 days)
r = +0.996, P = 0.0001 + (>7 days)
F, Day 1

+BS (> 7 days)
+ F, 7 & 15 Days

r = –0.901, P = 0.03
F, Day 15

+F, 7 & 15 Days &
r = +0.87, P = 0.02 &
r = +0.861, P = 0.02,
M, 7 & 15 Days

+ F, 7 & 15 Days

r = +0.914, P = 0.0108
M, 60 Days

r = +0.97, P = 0.0006
F, 30 days,
r = +0.97, P = 0.0006 &
r = +0.932, P = 0.006 & r = +0.943,
P = 0.004 & r = +0.828, P = 0.042
M, Days 1, 7 & 30 & 60

r = +0.983, P = 0.0004 &
r = +0.878, P = 0.02,
M, 15 & 30 Days

r= +0.9, P = 0.01
M, Day 7 &
r = +0.902, P = 0.01
M, 30 Days

HDL (mg/dL)

PON1 activity
(U/mL)

LDL
(mg/dL)
r = +0.688, P = 0.0193
r = +0.662, P = 0.0265
r= –0.643, P = 0.033
BS, Day 7 &
r = +0.706, P = 0.015
BS, r = +0.849, P = 0.0326 BS, Day 60 & r = +0.834,
R = +0.835, P = 0.048
BS, Day 7
M, Day 7
P = 0.0389 M, Day 7
M, Day 30

PON1 activity
(U/mL)

PON1 gene
expression

PON1 gene
expression

Table 4. The summary of significant correlations between different parameters.
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Figure 1. Changes in serum PON1 activity in female and male foals from birth up to the 60th
day of life.
a
Significant to day 1 (p < 0.05).

Figure 2. Changes in mRNA expression levels of PON1 in female and male foals
from birth up to the 60th day of life.
a
Significant to the birthday (p < 0.05).
c
Significant to the 15th day (p < 0.05).
d
Significant to the 30th day (p < 0.05).
e
Significant to the 60th day (p < 0.05).
A
Significant to another sex on the same day (p < 0.05).

in the study of Ruggerone et al. [14]. No significant sexdependent difference was observed in PON1 activity on
the first day of life. Contrary to this finding, PON1 gene
expression was significantly decreased up to 60 days of age,
and the sex-related differences in PON1 gene expression
were shown to that female foals have a higher level than
males on 60 days of age (p = 0.023). Thomàs-Moyà et al. [24]
emphasized that sex hormones can regulate and stabilize
PON1 activity at a higher level in young female rats, which
reduces with increasing age. Previous studies have shown

that inflammation, oxidative stress, hypolipidemic drugs,
and polyphenols can modulate liver PON1 expression
[25,26]. PON1 gene expression has also been reported
in the mouse kidney, lung, heart, and small intestine.
Therefore, PON1 has less tissue distribution compared to
PON2, which is exclusively recognized as an intracellular
antioxidant and expressed ubiquitously in tissues [27]. So,
the correlation between hepatic PON1 mRNA and serum
PON1 activity has been studied in laboratory animals, but
there is no report about their relationship in foals. Pearce
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et al. [16] considered that liver biopsy is so life-threatening
for newborn foals, which is why the authors decided to
determine the leukocyte PON1 mRNA. This study indicated
the presence of PON1 mRNA in foal leukocytes for the first
time, which contrasts with Rosenblat et al.’s [28] findings.
They reported the presence of PON2 and PON3 mRNA
but not PON1 in murine macrophages and proposed that
oxidative stress can regulate PON gene expression and
its activities in macrophages and the liver. The obtained
results contradict a previous study by Mackness et al. [27],
which found that human PON1 expression was restricted
to the liver, kidney, and colon. It was also confirmed that
the PON family can improve macrophage function by
reducing mitochondrial oxidant formation and preventing
the induction of apoptosis [17]. The authors suggest that
PON1 expression in leukocytes may be related to the
enzyme’s ability to reduce intracellular oxidant levels.
In the first week of life, a positive correlation was
observed between PON1 gene expression/cholesterol
(r = +0.706, p = 0.0151), PON1 gene expression/HDL
(r = +0.662, p = 0.0265) and PON1 gene expression/
LDL (r = +0.688, p = 0.0193), and then on the 60th day
of life, a negative correlation was recorded between
PON1 gene expression/triglyceride (r = –0.643, p
= 0.033) in both sexes. Antioxidant activity is very
important for growing foals. Neuroaxonal dystrophy
(NAD) and the related condition equine degenerative
myeloencephalopathy (EDM) are examples of these
conditions, which support a direct effect of antioxidant
activities on horse central nervous system (CNS) health
and function. It has been established that vitamin E
prevents oxidized cholesterol (oxysterol) formation,
lipid peroxidation, and demyelination [29, 30].
Our findings indicate an increase in PON1 activity and,
conversely, lower PON1 gene expression, LDL, cholesterol,
and triglyceride concentrations on the 60th day of sampling.
Numerous studies have reported a close physiological
association between PON1 and HDL in plasma [8, 31].
PON1 is considered one of the major contributors to
antioxidative HDL function [8]. In the present study, an
increase in PON1 activity was accompanied by an increase
in HDL concentration on days 15, 30, and 60 in male foals.
Increased serum PON1 activity may be a result of increased
synthesis of HDL. However, no positive correlation was
observed between PON1 enzyme activity and HDL on all
days. These data are inconsistent with previous studies by
Dullaart et al. [32] and Teimouri and Nayeri [33] which

documented serum PON1 activity correlated well with
HDL concentration and can be explained by the limited
duration of the present experiment. On the other hand, it
has been shown that PON1 inactivation could happen due
to high levels of triglycerides, LDL, and cholesterol [21,
33]. The possible mechanisms for PON inactivation due to
oxidation of LDL are related to the irreversible reaction of
oxidized lipids in Ox-LDL with the PON’s free sulfhydryl
[34]. In this study, an increase in PON1 activity was
observed along with a progressive decrease in LDL, TG,
and cholesterol levels compared to the first day of age. High
levels of cholesterol, TG, and LDL in newborn foals could
be related to colostrum and milk intake, which leads to
quantitative changes in blood lipid profile values and
lipoprotein composition as previously reported for
newborn calves [35]. These results also suggest that during
the early postnatal period, cholesterol spontaneously
transfers from LDLs to HDLs, leading to a gradual
increase in HDL levels. The mechanism by which colostrum
affects lipoprotein status in various species is unproven, but
it may be associated with the modifying effect of bioactive
components such as insulin and insulin-like growth factor
I on digestion and absorption of lipids, by possibly altering
lipase activity or fatty acid-binding proteins [36].
In conclusion, this study shows the low activity of
PON1 at birth, which increased with increasing age
and could provide appropriate support for enhancing
antioxidant supply in newborn foals. Changes in leukocyte
PON1 gene expression were recorded for the first time
and positive correlations between PON1 expression/
HDL, LDL, and cholesterol and PON1 enzyme activity/
HDL, LDL, and cholesterol in different samples and sexes
were achieved, which may indicate an adaptive increase
in antioxidant defenses in response to oxidative stress.
However, in this study, there were some limitations to
the use of Western blot quantification. Further studies
are needed to investigate the protein expression profile of
PON1 in leukocytes.
List of abbreviations
PON1: Paraoxonase- 1; HDL-C: High-density lipoprotein
cholesterol; TG: Triglycerides; TC: Total cholesterol;
LDL-C: Low-density lipoprotein cholesterol.
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